Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles. 2008

Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
Laboratoire SEESIB, Université Blaise Pascal, UMR 6504 du CNRS, 63177 Aubière, France.

In the course of structure-activity relationship studies on granulatimide analogues, new pyrrolo[3,4-c]carbazoles have been synthesized in which the imidazole heterocycle was replaced by a five-membered ring lactam system or a dimethylcyclopentanedione. Moreover, the synthesis of an original structure in which a sugar moiety is attached to the indole nitrogen and to a six-membered D ring via an oxygen is reported. The inhibitory activities of the newly synthesized compounds toward checkpoint kinase 1 and their in vitro antiproliferative activities toward three tumor cell lines: murine leukemia L1210, and human colon carcinoma HT29 and HCT116 are described.

UI MeSH Term Description Entries
D007094 Imides Organic compounds containing two acyl groups bound to NITROGEN. Imide
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071877 Checkpoint Kinase 1 A serine/threonine-specific protein kinase which is encoded by the CHEK1 gene in humans. Checkpoint kinase 1 (also known as Chk1) coordinates DNA damage response and cell cycle checkpoint response. Under these conditions, activation of Chk1 results in the initiation of cell cycle checkpoints, cell cycle arrest, DNA repair and cell death, to prevent damaged cells from progressing through the cell cycle. Checkpoint-1 Kinase,Chk1 Kinase,Chk1 Protein Kinase,Protein Kinase, Chk1
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
August 2008, Anti-cancer agents in medicinal chemistry,
Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
January 2017, Anti-cancer agents in medicinal chemistry,
Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
July 2011, Journal of medicinal chemistry,
Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
December 2006, European journal of medicinal chemistry,
Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
October 2009, Journal of medicinal chemistry,
Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
September 2008, Anti-cancer drugs,
Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
October 2007, Anti-cancer drugs,
Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
November 2003, Bioorganic & medicinal chemistry,
Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
September 2010, Bioorganic & medicinal chemistry,
Elisabeth Conchon, and Fabrice Anizon, and Bettina Aboab, and Roy M Golsteyn, and Stéphane Léonce, and Bruno Pfeiffer, and Michelle Prudhomme
April 2023, Bioorganic chemistry,
Copied contents to your clipboard!